C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: The PRIME study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 10, 2010, Pages 2047-2052

  Empana, Jean Philippe ^a   Jouven, Xavier ^a,b   Canouï Poitrine, Florence ^a   Luc, Gerald ^c   Tafflet, Muriel ^a   Haas, Bernadette ^d   Arveiler, Dominique ^d   Ferrieres, Jean ^e   Ruidavets, Jean Bernard ^e   Montaye, Michèle ^f   Yarnell, John ^g   Morange, Pierre ^h   Kee, Frank ^g   Evans, Alun ^g   Amouyel, Philippe ^f   Ducimetiere, Pierre ⁱ  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f UNIV LILLE   (France)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^h TIMONE HOSPITAL   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

atherosclerosis; epidemiology; risk factors; sudden death

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; AUTACOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FIBRINOGEN BLOOD LEVEL; HEART DEATH; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; METABOLISM; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; EUROPE; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77957691199     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.208785     Document Type: Article

References (25)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98: 2334-51.
2. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of-hospital cardiac arrest in Europe. Resuscitation. 2005;67:75-80.
3. Empana JP, Ducimetiere P, Charles MA, Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle aged men: the Paris prospective study I. Circulation. 2004;110:2781-2785.
4. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005;352:1951-1958. (Pubitemid 40638365)
5. Empana JP, Jouven X, Lemaitre RN, Sotoodehnia N, Rea T, Raghunathan TE, Simon G, Siscovick DS. Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006;166:195-200.
6. Jouven X, Schwartz PJ, Escolano S, Straczek C, Tafflet M, Desnos M, Empana JP, Ducimetiere P. Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur Heart J. 2009;30:1703-1710.
7. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB. Dietary a-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112:3232-3238. (Pubitemid 43739367)
8. Albert CM, Manson JE, Cook NR, Ajani UA, Gaziano JM, Hennekens CH. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation. 1999;100:944-950.
9. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311: 874-877.
10. Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JE. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107:2096-2101.
11. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-1140.
12. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, Carli P. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336:1629-1633.
13. Albert CM, Ma J, N Rifai MJ. Stampfer PM. Ridker prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105:2595-2599.
14. Korngold EC, Januzzi JL Jr, Gantzer ML, Moorthy MV, Cook NR, Albert CM. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation. 2009;119:2868-2876.
15. Kucharska-Newton AM, Couper DJ, Pankow JS, Prineas RJ, Rea TD, Sotoodehnia N, Chakravarti A, Folsom AR, Siscovick DS, Rosamond WD. Hemostasis, inflammation, and fatal and nonfatal coronary heart disease long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort. Arterioscler Thromb Vasc Biol. 2009;29:2182-2190.
16. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.
17. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, arveiler D, fruchart JC, Ducimetiere P. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol. 2003;23:1255-1261.
18. Sattar N, Murray HM, Welsh P, Blauw GJ, Buckley BM, Cobbe S, de Craen AJ, Lowe GD, Jukema JW, Macfarlane PW, Murphy MB, Stott DJ, Westendorp RG, Shepherd J, Ford I, Packard CJ. Prospective study of pravastatin in the elderly at risk (PROSPER) study group. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med. 2009 23;6:e1000099.
19. Ducimetiere P, Ruidavets JB, Montaye M, Haas B, Yarnell J. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the prospective epidemiological study of myocardial infarction (PRIME) study. Int J Epidemiol. 2001;30:1057-1062.
20. Luc G, Empana JP, Morange P, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Evans A, Kee F, Bingham A, Machez E, Ducimetière P. Adipocytokines and the risk of coronary heart disease in healthy middle aged men. The PRIME Study Int J Obes. 2010;34:118-126.
21. Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int. 2008;74: 1335-1342.
22. Empana JP, Ducimetiere P, Balkau B, Jouven X. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris prospective study I. Eur Heart J. 2007;28:1149-1154.
23. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021-2028.
24. Thompson AM, Zanobetti A, Silverman F, Schwartz J, Coull B, Urch B, Speck M, Brook JR, Manno M, Gold DR. Baseline repeated measures from controlled human exposure studies: associations between ambient air pollution exposure and the systemic inflammatory biomarkers IL-6 and fibrinogen. Environ Health Perspect. 2010;118:120-124.
25. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov A. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107-2116.